Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cisplatin and Gemcitabine in First-Line Treatment of Stage IIIb/IV Non-Small Cell Lung Cancer
NCT00006116Phase 2Unknown
- Sponsor
- GERCOR
- Start
- Apr 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cisplatin, gemcitabine in non-small cell lung cancer (NSCLC), sponsored by GERCOR. Status: unknown.
02
Drugs
cisplatingemcitabine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00006116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006116.